COPD Trial, Recruiting NCT06217276 Sponsor: Istanbul Medipol University Hospital Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06217276
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with COPD:

  • People who have been diagnosed with Stage 2 or Stage 3 COPD, based on guidelines set by the American Thoracic Society and European Respiratory Society
  • People who have been taking the same medications without any changes for at least the past 4 weeks

For healthy participants:

  • People who are 18 years of age or older
  • People who do not have any diagnosed chronic (long-term) illness
  • People who do not smoke

Who may not be able to join:

  • People who have serious other health conditions, unstable heart disease, certain diseases affecting connective tissue, or who need high levels of oxygen therapy (more than 3–4 litres per minute)
  • People who have any blood vessel problems in their legs that could affect blood flow or oxygen delivery to the leg muscles
  • People who have a lung or breathing condition other than COPD
  • People who have had a COPD flare-up (worsening of symptoms) in the last 4 weeks
  • People who experience a COPD flare-up while the study is already underway
  • People who have fatty tissue or scar tissue at the body sites where measurements would be taken, as this could affect the accuracy of results
  • People who have taken part in another clinical trial within the last 30 days that could influence this study's results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 09050585279

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istanbul Medipol University Hospital
Registry
ClinicalTrials.gov
Start date
20 January 2024
Est. completion
15 January 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Lower extremity muscle oxygenation level measurement; Lower extremity muscle total hemoglobin amount level measurement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov